Posts Tagged ‘news’

This April, taxpayers will need to enter the number code “21” to donate to the Oregon Partnership for Alzheimer’s Research, according to OHSU Strategic Communications. In years past, you could donate to the fund by simply checking a box on your Oregon state tax forms 40 and 40S, but because of the growing number of charities receiving donations from tax forms, this year you’ll need to remember the number “21.” The Oregon Partnership for Alzheimer’s … Read More

If you are planning on submitting an NIH grant in the next 10 days, please read the important updates below. Research Grants & Contracts would like to alert those of you planning to submit K series grant due February 12, and those of you working on R03, R21, R33, R21/R33, R34, R36 applications due on February 16, of some potential issues regarding submission: Grants.gov, the internet portal used to transmit your application to NIH and … Read More

Brian Druker, MD, and OHSU’s Knight Cancer Leadership congratulate their Prostate Cancer Research team for being the Prostate Cancer Clinical Trials Consortium’s (PCCTC) top clinical trials accrual site for 2009. The PCCTC is a national clinical research group sponsored by the Prostate Cancer Foundation and the Department of Defense. It is a major multi-institutional clinical research endeavor consisting of 13 academic institutions specializing in cutting-edge prostate cancer research with a single coordinating center located at … Read More

Research News has moved to a new public format: it can now be accessed from any computer–both on campus and off. You will never need to miss important information from us again because you are sitting in an airport and don’t feel like logging into the WTS. Research News can still be accessed using the old URL, but we recommend updating your bookmarks to the new URL: http://portal.ohsu.edu/blogs/researchnews/. For information on how to set up an … Read More

Miss the big news last week? Dr. Brian Druker, director of the Knight Cancer Institute, has received the prestigious Lasker-DeBakey Award for Clinical Medical Research for his research and development of Gleevec. Read about the award and his research in the Staff News article here.

The Oregon Clinical and Translational Research Institute is pleased to announce the awardees of 2009 OCTRI Pilot Project funding.  In addition to the OCTRI traditional and career Pilot Project funding, this round included a focused RFA for Child Health projects, funded jointly by OCTRI and the OHSU Department of Pediatrics.  The one-year Pilot Project funding is designed to stimulate preliminary data in novel research directions, and ultimately to launch new nationally funded research programs. OCTRI … Read More

If you wanted to study patterns of care or quality of care for people who have no insurance, where would you go? You can’t go to Medicaid, Medicare, or private insurance claims to find people without insurance. You might go to low-cost clinics, but you’d have to find them one by one, and in many cases you’d have to sort through paper records in a slow, painful process. The Oregon Clinical and Translational Research Institute … Read More

Great news – the NIH announced Friday that it would be re-issuing and expanding the NIH Director’s Bridge Award for 2009. This award provides continued but limited bridge funding for meritorious investigators who just miss the funding cutoff and have minimal support from other sources for their research. The continued funding will give the PI more time to strengthen a resubmission application. If your R01 competitive renewal or resubmission application is just shy of the … Read More

If you were unable to attend the NIH Challenge Grant brownbag session on March 16th, read below for questions and answers that were addressed in the session. You can also access a .pdf of the FAQs here. We will continue to add and update as we get more information. If you have other questions, contact funding@ohsu.edu. ARRA – NIH Challenge Grants Frequently Asked Questions Q: What are the NIH Challenge Grants in Health & Science … Read More

Several pieces of new communication released by the NIH this week indicate that small businesses are eligible to apply for Challenge Grants from the NIH. While no funds were specifically set aside for SBIR/STTR applications, the NIH assures us that small businesses are eligible to compete for the general pool of Challenge Grant funds. For specific topics and challenge areas, see the full announcement.